IL142831A0 - An unusual retrotransposon from the yeast candida albicans - Google Patents

An unusual retrotransposon from the yeast candida albicans

Info

Publication number
IL142831A0
IL142831A0 IL14283199A IL14283199A IL142831A0 IL 142831 A0 IL142831 A0 IL 142831A0 IL 14283199 A IL14283199 A IL 14283199A IL 14283199 A IL14283199 A IL 14283199A IL 142831 A0 IL142831 A0 IL 142831A0
Authority
IL
Israel
Prior art keywords
retrotransposon
unusual
candida albicans
yeast candida
yeast
Prior art date
Application number
IL14283199A
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2249046 external-priority patent/CA2249046A1/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL142831A0 publication Critical patent/IL142831A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/905Stable introduction of foreign DNA into chromosome using homologous recombination in yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1276RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/90Vectors containing a transposable element

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL14283199A 1998-10-30 1999-11-01 An unusual retrotransposon from the yeast candida albicans IL142831A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10634298P 1998-10-30 1998-10-30
CA 2249046 CA2249046A1 (en) 1998-10-30 1998-10-30 An unusual retrotransposon from the yeast candida albicans
PCT/NZ1999/000179 WO2000026397A1 (en) 1998-10-30 1999-11-01 AN UNUSUAL RETROTRANSPOSON FROM THE YEAST $i(CANDIDA ALBICANS)

Publications (1)

Publication Number Publication Date
IL142831A0 true IL142831A0 (en) 2002-03-10

Family

ID=25680530

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14283199A IL142831A0 (en) 1998-10-30 1999-11-01 An unusual retrotransposon from the yeast candida albicans

Country Status (6)

Country Link
EP (1) EP1124978A4 (en)
JP (1) JP2003512014A (en)
AU (2) AU774371B2 (en)
IL (1) IL142831A0 (en)
NZ (1) NZ511224A (en)
WO (1) WO2000026397A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE353367T1 (en) 1998-12-22 2007-02-15 Microscience Ltd GROUP B STREPTOCOCCUS PROTEINS AND THEIR USE
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
AU2001278421A1 (en) * 2000-04-26 2001-11-07 Janssen Pharmaceutica N.V. Multiple retrotransposon families in candida albicans
WO2004020627A2 (en) * 2002-08-29 2004-03-11 Andreas Beck Improved dna and proteins
CN111088278B (en) * 2019-12-31 2023-06-27 中山大学 Retrotransposon Ra-RARE-1 with autonomous transposition activity and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8171087A (en) * 1986-10-27 1988-05-25 Whitehead Institute For Biomedical Research Gene amplification using retrotransposons

Also Published As

Publication number Publication date
JP2003512014A (en) 2003-04-02
EP1124978A1 (en) 2001-08-22
EP1124978A4 (en) 2003-11-12
AU774371B2 (en) 2004-06-24
AU2004210616B2 (en) 2007-03-29
NZ511224A (en) 2003-10-31
AU2004210616A1 (en) 2004-10-07
WO2000026397A1 (en) 2000-05-11
AU1084700A (en) 2000-05-22

Similar Documents

Publication Publication Date Title
AU2994799A (en) Metal nanoshells
HK1030387A1 (en) Shank fitting structure.
EP1141651A4 (en) Shotshell basewad
AU2567001A (en) Metal air-bag
HRP980253B1 (en) Wall structure
AU5165700A (en) Terminal design
GB9811103D0 (en) Yeast
AU5975100A (en) Deformation projectile
AU1656499A (en) New (candida albicans) kre9 and uses thereof
AU6220098A (en) Artificial wall structure
IL142831A0 (en) An unusual retrotransposon from the yeast candida albicans
AU2001298090A1 (en) Multifunctional allyl carbamates and coatings therefrom
GB9810442D0 (en) Yeast
AU7059000A (en) Multimodal structured hardcoatings made from micro-nanocomposite materials
AU2936800A (en) Memory with call out function
AU6164800A (en) Level sensor-switch
AU9233001A (en) Drying-resistant yeast
AU2204397A (en) Candida albicans profilin gene
AU6219998A (en) Artificial wall structure
AU139508S (en) In-store wall
GB2355040B (en) An improved hod
AU6063300A (en) Wall structure
ZA9710779B (en) Retaining wall.
AU1055901A (en) Ether-type gla-60 analogues
GB9828194D0 (en) Wall